Atlas Venture Fund Xii, L.p. - Net Worth and Insider Trading
Atlas Venture Fund Xii, L.p. Net Worth
The estimated net worth of Atlas Venture Fund Xii, L.p. is at least $20 Million dollars as of 2024-09-20. Atlas Venture Fund Xii, L.p. is the 10% Owner of Vigil Neuroscience Inc and owns about 5,836,874 shares of Vigil Neuroscience Inc (VIGL) stock worth over $20 Million. Details can be seen in Atlas Venture Fund Xii, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Atlas Venture Fund Xii, L.p. has not made any transactions after 2022-01-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Atlas Venture Fund Xii, L.p.
Atlas Venture Fund Xii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Atlas Venture Fund Xii, L.p. owns 3 companies in total, including Aerovate Therapeutics Inc (AVTE) , Disc Medicine Inc (IRON) , and Vigil Neuroscience Inc (VIGL) .
Click here to see the complete history of Atlas Venture Fund Xii, L.p.’s form 4 insider trades.
Insider Ownership Summary of Atlas Venture Fund Xii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVTE | Aerovate Therapeutics Inc | 2021-06-29 | 10 percent owner |
| IRON | Disc Medicine Inc | 2021-02-05 | 10 percent owner |
| VIGL | Vigil Neuroscience Inc | 2022-01-11 | 10 percent owner |
Atlas Venture Fund Xii, L.p. Latest Holdings Summary
Atlas Venture Fund Xii, L.p. currently owns a total of 1 stock. Atlas Venture Fund Xii, L.p. owns 5,836,874 shares of Vigil Neuroscience Inc (VIGL) as of January 11, 2022, with a value of $20 Million.
Latest Holdings of Atlas Venture Fund Xii, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VIGL | Vigil Neuroscience Inc | 2022-01-11 | 5,836,874 | 3.44 | 20,050,830 |
Holding Weightings of Atlas Venture Fund Xii, L.p.
Atlas Venture Fund Xii, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Atlas Venture Fund Xii, L.p. has made a total of 1 transactions in Vigil Neuroscience Inc (VIGL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Vigil Neuroscience Inc is the acquisition of 535,000 shares on January 11, 2022, which cost Atlas Venture Fund Xii, L.p. around $7 Million.
Insider Trading History of Atlas Venture Fund Xii, L.p.
- 1
Atlas Venture Fund Xii, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Atlas Venture Fund Xii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Atlas Venture Fund Xii, L.p. is -45.7%. GuruFocus also compares Atlas Venture Fund Xii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Atlas Venture Fund Xii, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Atlas Venture Fund Xii, L.p.'s insider trading performs compared to the benchmark.
Performance of Atlas Venture Fund Xii, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 31.96 | | | | | |
| Relative Return to S&P 500(%) | 38.21 | | | | | |
Atlas Venture Fund Xii, L.p. Ownership Network
Atlas Venture Fund Xii, L.p. Owned Company Details
What does Aerovate Therapeutics Inc do?
Who are the key executives at Aerovate Therapeutics Inc?
Atlas Venture Fund Xii, L.p. is the 10 percent owner of Aerovate Therapeutics Inc. Other key executives at Aerovate Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , See Remarks George A Eldridge , and SENIOR VICE PRESIDENT & CMC Marinus Verwijs .
Aerovate Therapeutics Inc (AVTE) Insider Trades Summary
Over the past 18 months, Atlas Venture Fund Xii, L.p. made no insider transaction in Aerovate Therapeutics Inc (AVTE). Other recent insider transactions involving Aerovate Therapeutics Inc (AVTE) include a net sale of 68,255 shares made by Hunter Gillies , a net sale of 152,284 shares made by Benjamin T Dake , and a net sale of 93,142 shares made by Timothy P Noyes .
In summary, during the past 3 months, insiders sold 0 shares of Aerovate Therapeutics Inc (AVTE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 452,068 shares of Aerovate Therapeutics Inc (AVTE) were sold and 928,110 shares were bought by its insiders, resulting in a net purchase of 476,042 shares.
Aerovate Therapeutics Inc (AVTE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aerovate Therapeutics Inc Insider Transactions
Atlas Venture Fund Xii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Atlas Venture Fund Xii, L.p.. You might contact Atlas Venture Fund Xii, L.p. via mailing address: 400 Technology Square, 10th Floor, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
